This study investigates the safety and effectiveness of an investigational medication in people with Cystic Fibrosis who have a chronic Pseudomonas infection. Cystic Fibrosis is a genetic disorder that affects the lungs and digestive system. Pseudomonas is a type of bacteria that can cause lung infections in people with Cystic Fibrosis.
Participants in the study will receive multiple doses of the investigational medication. The study will include procedures to monitor the safety and effectiveness of the treatment, which might involve regular check-ups and tests to assess lung function and infection levels.
- Who can participate: Participants must meet age criteria and key eligibility factors, which will be specified by the study.
- Study details: Participants will receive multiple doses of an investigational medication. Regular monitoring will be conducted to evaluate the treatment's impact on lung function and infection.
